EP2498759
Töflusamsetningar með tafarlausa losun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.11.2010EP published:
1.8.2018EP application number:
10782116.7
EP translation filed:
29.10.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
11.11.2030Expiry date:
11.11.2026Next due date:
30.11.2026
Title:
IMMEDIATE RELEASE TABLET FORMULATIONS
Timeline
Today
12.11.2010EP application
1.8.2018EP Publication
29.10.2018Translation submitted
15.11.2018Registration published
11.11.2026Expires
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Name:
AstraZeneca UK LimitedAddress:
1 Francis Crick Avenue, Cambridge Biomedical CampusCambridge CB2 0AA, GB
Inventor
Name:
HALLGREN, AgnetaAddress:
431 83 Molndal, SE
Name:
SWENSON, Ralf Magnus WernerAddress:
431 83 Molndal, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
261173 PDate:
13.11.2009Country:
US
Classification
Categories:
A61K 9/20, A61K 31/155, A61K 31/351, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 5.10.2018
Expires: 11.11.2019
Payer: Árnason Faktor
Number: 10
Paid: 8.10.2019
Expires: 11.11.2020
Payer: Árnason Faktor
Number: 11
Paid: 6.10.2020
Expires: 11.11.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.10.2021
Expires: 11.11.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.10.2022
Expires: 11.11.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 9.11.2023
Expires: 11.11.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.10.2024
Expires: 11.11.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.11.2025
Expires: 11.11.2026
Payer: Árnason Faktor ehf.